Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned

Jul.08
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.

Key Points

  • Hawaii enacted two new laws tightening e-cigarette regulations.
  • Vape products must have FDA Marketing Granted Order authorization.
  • The state will publish a directory of approved products.
  • Disposable e-cigarettes will be banned from 2027.
  • Regulators cited youth protection and environmental concerns.

2Firsts

July 8, 2026

Hawaii has introduced stricter e-cigarette regulations after Gov. Josh Green signed two laws that tighten product requirements and restrict disposable vape sales.

FDA Authorization Becomes Market Entry Requirement

House Bill 1573 requires e-cigarette and e-liquid manufacturers to submit annual certification to Hawaii’s Attorney General confirming compliance with state and federal requirements, including proof of FDA Marketing Granted Order authorization.

The state will establish a public directory listing certified brands, products and manufacturers. Products not included in the directory will face enforcement action.

State lawmakers said the measure will not eliminate vaping products entirely but will significantly reduce the number of products legally available in Hawaii.

Disposable E-Cigarettes to Face 2027 Ban

Senate Bill 2175 prohibits the sale of disposable electronic smoking devices in Hawaii beginning Jan. 1, 2027.

The measure targets disposable devices containing lithium-ion batteries, with lawmakers citing both waste concerns and potential environmental risks.

Violations of the disposable vape ban may result in fines.

However, disposable devices with FDA Marketing Granted Orders, such as currently authorized NJOY DAILY products, are exempt from the ban.

Hawaii Moves Toward a Smaller Authorized Market

Hawaii officials said the new regulations are not intended as a complete prohibition of vaping products, but rather as a way to narrow the legal market through FDA authorization requirements.

The state said many flavored and youth-attractive products currently sold are not FDA-authorized and would face greater restrictions under the new framework.

Officials said reducing unauthorized product availability is intended to limit youth access to vaping products.

Industry Impact and Outlook

Hawaii’s new rules represent a shift from traditional sales restrictions toward product authorization-based regulation.

Rather than simply banning categories of products, HB1573 creates a market filter based on FDA authorization status, making Marketing Granted Orders a key requirement for companies seeking access to Hawaii consumers.

For manufacturers, the rules may increase compliance costs related to product certification, documentation and ongoing regulatory monitoring. The disposable vape ban may also accelerate product shifts toward reusable devices, pod systems and other authorized formats.

The Hawaii case reflects two broader trends in U.S. vaping regulation: increased reliance on FDA authorization as a market gatekeeper and growing policy pressure on disposable products due to environmental and public health concerns.

Whether other states adopt similar approaches will be an important factor shaping the future U.S. e-cigarette market.

Follow 2Firsts for the latest updates on global tobacco harm reduction, nicotine products and regulatory developments.

Cover Image source: Aloha State Daily


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Pennsylvania’s June 26 ENDS Pending Certifications list previews the state’s future legal vape market, placing Vuse, JUUL and Logic alongside Chinese-linked disposable brands OXBAR and LYCO. Shaped by PMTA eligibility and state rules, the list shows competition shifting from market share to market access.
Special Report
Jul.06
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
 Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
The Washington Examiner published an opinion article by Tricia McLaughlin, former Assistant Secretary for Public Affairs and spokesperson at the U.S. Department of Homeland Security, arguing that the Trump administration is strengthening enforcement against illegal vape supply chains through the FDA, CBP, and DHS.
Regulations
May.25